Merck Says European Medicines Agency's CHMP Adopted Positive Opinions Recommending Approval Of Keytruda (Pembrolizumab), Its Anti-PD-1 Therapy, For Two Indications In Gynecologic Cancers
J&J Said to Boost Offer to Settle Baby Powder Lawsuits to Over $8.2B
The Bank of Japan remains unchanged, providing assistance to the booming global stock market.
The Bank of Japan remains unchanged, indicating that it will not rush to continue tightening monetary policy after the unexpected rate hike in July.
Behind the Scenes of Amgen's Latest Options Trends
Abbott Laboratories' Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst
Tandem Diabetes Rises as Insulin Pump Cleared for Use in EU With Lilly Insulin
Abbott a New Overweight at Piper Sandler; at Attractive Entry Point
Weight Loss Drug Developer BioAge Seeks up to $602M Valuation in U.S. IPO
Is the Federal Reserve starting an interest rate cut cycle on the cusp of a wave, possibly revealing the outcome of the election in advance?
Taking history as a lesson, in an election year with declining interest rates, the probability of the incumbent president or challenger winning is greater.
Competitor Analysis: Evaluating AbbVie And Competitors In Biotechnology Industry
Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target
Johnson & Johnson Analyst Ratings
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Thermo Fisher Scientific Hosts 2024 Investor Day, Showcasing Industry-Leading Businesses, Proven Growth Strategy, And Strong Long-Term Financial Outlook
Vanda Slips as FDA Rejects Therapy for Stomach Condition
Abbott Laboratories Analyst Ratings
Several value stock ETFs have reached new highs! Will the uptrend continue with the start of the interest rate cut cycle?
Nomura Securities found that after studying historical rate-cut cycles, three months after the Fed cut interest rates by 50 basis points, the performance of value stocks outperformed growth stocks.
Unmissable investment strategy! The Federal Reserve officially enters a new era of interest rate cuts, these 6 industries have the most profitable potential.
Prepare yourself for the interest rate cut cycle.
BeiGene Initiated at Outperform at JMP Securities on Strength of Brukinsa
Merck's Keytruda Secures First FDA-Approval For Rare Form Aggressive Cancer